Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-23-004744

Options or other derivatives

  • Controller acquired 16,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tourangeau Greg Controller 2023-02-09 Grant or award · Stock Option (right to buy) +16,100 16,100 D
Loading xslF345X03/doc4.xml…